Psoriasis Clinical Trials

Links shared publicly online about this topic

PhotoMedex to Begin Laser Treatment of Psoriasis Clinical Trials (photonics.com | Jun 2010 | Business)

photonics.com — “As an extension of his article titled, The value of discovery in the Oct. issue of Photonics Spect...View full resource at photonics.com

  • View Related
  • Share

Most Recently Shared on June 25, 2010 at 8:44 pm By:

Abbott psoriasis drug succeeds in pivotal trial

health.yahoo.net — “Abbott Laboratories' experimental psoriasis treatment briakinumab, which is awaiting U.S. and European approval decisions, demonstrated superior skin clearance rates compared with a commonly used medicine in a pivotal late-stage clinical trial, the company said on Monday.View full resource at health.yahoo.net

  • View Related
  • Share

Most Recently Shared on October 11, 2010 at 5:57 pm By:

JennyBizRN Jennifer Ann Grisso Nurse and Active Health Library

Abbott psoriasis drug succeeds in pivotal trial: Abbott Laboratories' experimental psoriasis treatment briakinumab... http://bit.ly/91X2Mp

2 years ago...

Abbott psoriasis drug succeeds in pivotal trial | Reuters

reuters.com — “NEW York (Reuters) - Abbott Laboratories' experimental psoriasis treatment briakinumab, which is awaiting U.S. and European approval decisions, demonstrated superior skin clearance rates compared withView full resource at reuters.com

  • View Related
  • Share

Most Recently Shared on October 12, 2010 at 3:08 pm By:

Psoriasis_OW Psoriasis OW OW Health

Abbott psoriasis drug succeeds in pivotal trial: NEW York (Reuters) - Abbott Laboratories' experimental psoriasis ... http://bit.ly/cpbFGm

2 years ago...

Abbott psoriasis drug succeeds in pivotal trial | Reuters

reuters.com — “NEW York (Reuters) - Abbott Laboratories' experimental psoriasis treatment briakinumab, which is awaiting U.S. and European approval decisions, demonstrated superior skin clearance rates compared withView full resource at reuters.com

  • View Related
  • Share

Most Recently Shared on October 11, 2010 at 4:30 pm By:

Reuters_Health Reuters Health Health News

Abbott psoriasis drug succeeds in pivotal trial http://dlvr.it/6txmj

2 years ago...

Abbott psoriasis drug succeeds in pivotal trial | Reuters

reuters.com — “NEW York (Reuters) - Abbott Laboratories' experimental psoriasis treatment briakinumab, which is awaiting U.S. and European approval decisions, demonstrated superior skin clearance rates compared withView full resource at reuters.com

  • View Related
  • Share

Most Recently Shared on October 11, 2010 at 8:45 pm By:

hrana Hisham Rana, MD Doctor and Physician

News: Abbott psoriasis drug briakinumab succeeds in pivotal trial http://reut.rs/dc3P5X - #health #pharma

2 years ago...

Clinical Trial Offers New Hope for Moderate to Severe Psoriasis Sufferers

xtraclaser.com — “Clinical Trial Offers New Hope for Moderate to Severe Psoriasis SufferersView full resource at xtraclaser.com

  • View Related
  • Share

Most Recently Shared on April 8, 2011 at 10:44 pm By:

Idera commences IMO-3100 Phase 2 clinical trial for psoriasis

news-medical.net — “Idera Pharmaceuticals, Inc. today announced the treatment of the first patient in a Phase 2 clinical trial of IMO-3100, the Company's lead Toll-like receptor (TLR) inhibitor for the treatment of autoimmune diseases, in patients with moderate to severe plaque psoriasis.View full resource at news-medical.net

  • View Related
  • Share

Most Recently Shared on April 18, 2012 at 6:26 am By:

NewsMedical News-Medical.Net Health News

Idera commences IMO-3100 Phase 2 clinical trial for psoriasis: Idera Pharmaceuticals, Inc. today announced the t... http://t.co/wEfJcG0T

1 month ago...

Clinical Trial Offers New Hope for Moderate to Severe Psoriasis Sufferers - Drugs.com MedNews

drugs.com — “Study using the XTRAC Velocity 700 excimer laser shows signs of relief for psoriasis patients MONTGOMERYVILLE, Pa., PhotoMedex, Inc. (Nasdaq PHMD) announced todView full resource at drugs.com

  • View Related
  • Share

Most Recently Shared on March 29, 2011 at 1:01 pm By:

Drugs_Devices Drugs and Devices OW OW Health

Clinical Trial Offers New Hope for Moderate to Severe Psoriasis Sufferers: Study using the XTRAC® Velocity... http://bit.ly/gNCz4P #drug

1 year ago...

PhotoMedex Announces Clinical Trial Using The XTRAC Velocity(R) Laser In The Treatment Of Severe Generalized Psoriasis

medicalnewstoday.com — “PhotoMedex, Inc. (Nasdaq: PHMD) announced that John Koo, MD will be the principal investigator in a clinical study assessing the efficacy of the XTRAC Velocity® excimer laser in the treatmentView full resource at medicalnewstoday.com

  • View Related
  • Share

Most Recently Shared on June 9, 2010 at 3:10 pm By:

mnt_dermatology MNT Dermatology News Dermatology and Health News

PhotoMedex Announces Clinical Trial Using The XTRAC Velocity(R) Laser In The Treatment Of Severe Generalized Psoriasis http://mnt.to/3DGW

2 years ago...

VBL Therapeutics Initiates Phase 2 Clinical Trial Of VB-201 In Patients With Psoriasis

medicalnewstoday.com — “VBL Therapeutics announced the initiation of a Phase 2 efficacy and safety study evaluating lead compound VB-201 for the treatment of patients with psoriasis. VB-201 is poised to be a first-in-claView full resource at medicalnewstoday.com

  • View Related
  • Share

Most Recently Shared on January 7, 2010 at 9:09 pm By:

mnt_clinical MNT Clinical Trials Health News

VBL Therapeutics Initiates Phase 2 Clinical Trial Of VB-201 In Patients With Psoriasis http://mnt.to/3w3y

2 years ago...

CalciMedica Initiates Phase I Clinical Trial Of First CRAC Channel Inhibitor (CCI) For Psoriasis

medicalnewstoday.com — “CalciMedica, a biotechnology company developing small molecules to treat inflammatory and autoimmune diseases, announced that it has dosed the first cohort in a Phase 1 clinical trial of CM2489. CView full resource at medicalnewstoday.com

  • View Related
  • Share

Most Recently Shared on February 18, 2011 at 4:01 pm By:

Psoriasis_OW Psoriasis OW OW Health

CalciMedica Initiates Phase I Clinical Trial Of First CRAC Channel Inhibitor (CCI) For Psoriasis: CalciMedica, a... http://mnt.to/f/3RkC

1 year ago...

Putting Psoriasis Drugs To The Test

medicalnewstoday.com — “Clinical trials to test the effectiveness of two prescription drugs for the debilitating skin condition psoriasis have revealed significant differences that should help inform physicians treatingView full resource at medicalnewstoday.com

  • View Related
  • Share

Most Recently Shared on January 15, 2010 at 1:12 pm By:

Welichem completes two Phase II clinical trials of cream for psoriasis, atopic dermatitis - Pharmaceutical Business Review

pharmaceutical-business-review.com — “Welichem Biotech, a biotechnology company developing therapeutic drugs for autoimmune disease and cancer, completed two Phase II clinical trials withView full resource at pharmaceutical-business-review.com

  • View Related
  • Share

Most Recently Shared on February 3, 2011 at 3:02 pm By:

Psoriasis_OW Psoriasis OW OW Health

Welichem completes two Phase II clinical trials of cream for psoriasis, atopic dermatitis: Welichem Biotech, a b... http://bit.ly/dVVK86

1 year ago...

Patient accrual complete in Provectus PH-10 Phase 2C clinical trial for treatment of psoriasis

news-medical.net — “Provectus Pharmaceuticals, Inc., a development-stage oncology and dermatology biopharmaceutical company, has completed patient accrual in its Phase 2C clinical trial of PH-10 for the treatment of psoriasis. PH-10, an aqueous hydrogel formulation of Rose Bengal disodium for topical administration to the skin, is being studied for the treatment of cutaneous skin disorders, specifically psoriasis and atopic dermatitis.View full resource at news-medical.net

  • View Related
  • Share

Most Recently Shared on May 24, 2011 at 3:56 pm By:

Psoriasis_OW Psoriasis OW OW Health

Patient accrual complete in Provectus PH-10 Phase 2C clinical trial for treatment of psoriasis: Provectus Pharma... http://bit.ly/mhMuNr

1 year ago...

Impact of Adalimumab on Symptoms of Psoriatic Arthritis in Patients with Moderate to Severe Psoriasis: A Pooled Analysis of Randomized Clinical Trials

content.karger.com — “Impact of Adalimumab on Symptoms of Psoriatic Arthritis in Patients with Moderate to Severe Psoriasis: A Pooled Analysis of Randomized Clinical TrialsView full resource at content.karger.com

  • View Related
  • Share

Most Recently Shared on February 3, 2010 at 7:42 pm By:

PsoriasisTx PsoriasisTx.com Dermatology and Health Site

Adalimumab in PsA. http://content.karger.com/ProdukteDB/produkte.asp?Aktion=ShowAbstract&ArtikelNr=260371&Ausgabe=253839&ProduktNr=224164

2 years ago...

The Top 3 resources shared on this topic. More resources.

Key stats and trends about this topic

Related Health Centers

Featuring the top 3 experts for this topic

  • ccoman

    National Psoriasis Foundation

    NPF is the world's largest patient advocacy organization for people with psoriasis and psoriatic arthritis.

    View Profile

  • JennyBizRN

    Jennifer Ann Grisso

    Jennifer, RN,BSN Business Minded RN, Over 20 years as an RN in most areas.Chicagoan !Great sense of humor. Learning and studying HIT. Sold Medical Supplies and Devices. Nursing experience in most areas, more in Cardiac.

    View Profile

  • Psoriasis_OW

    Psoriasis OW

    Organizing psoriasis resources shared by health experts, advocates, and organizations into WisdomCards.

    View Profile

Advertisement

Share via Email

Share this WisdomCard with others by embedding on your site or blog.

300x260

425x300

560x390